PuSH - Publikationsserver des Helmholtz Zentrums München

Petzold, C.* ; Schallenberg, S.* ; Stern, J.N.* ; Kretschmer, K.*

Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.

Rev. Diabet. Stud. 9, 305-318 (2012)
DOI Verlagsversion bestellen
Dendritic cells (DCs) and Foxp3-expressing CD4⁺ regulatory T (Treg) cells play non-redundant roles in the maintenance of peripheral tolerance to self-antigens, thereby preventing fatal autoimmunity. A common hallmark of intra- and extra-thymic Treg cell lineage commitment is the induction of Foxp3 expression as a consequence of appropriate T cell receptor engagement with MHC class II:agonist ligand. It has now become increasingly clear that agonist ligand presentation by immature DCs in the steady state induces T cell tolerance by both recessive and dominant mechanisms, rather than promoting productive T helper cell responses. In this context, the ability of steady-state DCs to promote the extrathymic conversion of initially naïve CD4⁺Foxp3⁻ T cells into Foxp3⁺ Treg cells is of particular interest as it provides novel perspectives to enhance antigen-specific Treg cell function in clinical settings of unwanted immunity, such as β-cell autoimmunity.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
ISSN (print) / ISBN 1613-0575
e-ISSN 1614-0575
Quellenangaben Band: 9, Heft: 4, Seiten: 305-318 Artikelnummer: , Supplement: ,
Verlag SBDR
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Pancreatic Beta Cell Research (IPI)